BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29409706)

  • 1. Blocking Ras inhibition as an antitumor strategy.
    Marín-Ramos NI; Ortega-Gutiérrez S; López-Rodríguez ML
    Semin Cancer Biol; 2019 Feb; 54():91-100. PubMed ID: 29409706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct inhibition of RAS: Quest for the Holy Grail?
    Spencer-Smith R; O'Bryan JP
    Semin Cancer Biol; 2019 Feb; 54():138-148. PubMed ID: 29248537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-Ras protein as a drug target.
    McCormick F
    J Mol Med (Berl); 2016 Mar; 94(3):253-8. PubMed ID: 26960760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).
    Sacco E; Spinelli M; Vanoni M
    Expert Opin Ther Pat; 2012 Nov; 22(11):1263-87. PubMed ID: 23009088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of RAS: proven and potential vulnerabilities.
    Zuberi M; Khan I; O'Bryan JP
    Biochem Soc Trans; 2020 Oct; 48(5):1831-1841. PubMed ID: 32869838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioblockades join the assault on small G protein signalling.
    Mott HR; Owen D
    Semin Cancer Biol; 2019 Feb; 54():149-161. PubMed ID: 29307570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of RAS: New hope for drugging the "undruggable".
    Khan I; Rhett JM; O'Bryan JP
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118570. PubMed ID: 31678118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Approaches to RAS Mutation.
    Scott AJ; Lieu CH; Messersmith WA
    Cancer J; 2016; 22(3):165-74. PubMed ID: 27341593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology, pathology, and therapeutic targeting of RAS.
    Rhett JM; Khan I; O'Bryan JP
    Adv Cancer Res; 2020; 148():69-146. PubMed ID: 32723567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.
    Yang WS; Yeo SG; Yang S; Kim KH; Yoo BC; Cho JY
    Amino Acids; 2017 Sep; 49(9):1469-1485. PubMed ID: 28631011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras proteins as therapeutic targets.
    Chakraborty A; Linnane E; Ross S
    Biochem Soc Trans; 2018 Oct; 46(5):1303-1311. PubMed ID: 30154091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in Ras therapeutics in pancreatic cancer.
    Choi M; Bien H; Mofunanya A; Powers S
    Semin Cancer Biol; 2019 Feb; 54():101-108. PubMed ID: 29170065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Endeavours in RAS Inhibition - the Past, Present, and Future.
    Hussain J; Kirubakaran S; Ravi S
    Curr Top Med Chem; 2020; 20(29):2708-2722. PubMed ID: 32885752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Ras palmitoylation/depalmitoylation cycle in cancer.
    Lin DTS; Davis NG; Conibear E
    Biochem Soc Trans; 2017 Aug; 45(4):913-921. PubMed ID: 28630138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view.
    Lu S; Jang H; Gu S; Zhang J; Nussinov R
    Chem Soc Rev; 2016 Sep; 45(18):4929-52. PubMed ID: 27396271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the RAS-dependent chemoresistance: The Warburg connection.
    Serna-Blasco R; Sanz-Álvarez M; Aguilera Ó; García-Foncillas J
    Semin Cancer Biol; 2019 Feb; 54():80-90. PubMed ID: 29432815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives.
    Asati V; Mahapatra DK; Bharti SK
    Eur J Med Chem; 2017 Jan; 125():299-314. PubMed ID: 27688185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective.
    Sautier B; Nising CF; Wortmann L
    Angew Chem Int Ed Engl; 2016 Dec; 55(52):15982-15988. PubMed ID: 27635522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Prospects for Targeting RAS.
    Singh H; Longo DL; Chabner BA
    J Clin Oncol; 2015 Nov; 33(31):3650-9. PubMed ID: 26371146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.
    Michael JV; Goldfinger LE
    Semin Cancer Biol; 2019 Feb; 54():121-130. PubMed ID: 29203271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.